Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-3.28%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$14.6B
AUM Growth
+$1.44B
(+11%)
Cap. Flow
+$1.76B
Cap. Flow
% of AUM
12.06%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
649
New
145
Increased
154
Reduced
121
Closed
154
Top Buys
| 1 |
AerCap
AER
|
+$212M |
| 2 |
Adobe
ADBE
|
+$160M |
| 3 |
Analog Devices
ADI
|
+$154M |
| 4 |
Salesforce
CRM
|
+$109M |
| 5 |
Paycom
PAYC
|
+$109M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$164M |
| 3 |
Dollar Tree
DLTR
|
+$148M |
| 4 |
Vertiv
VRT
|
+$144M |
| 5 |
Dell
DELL
|
+$122M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Consumer Discretionary | 16.17% |
| 3 | Industrials | 14.74% |
| 4 | Healthcare | 13.71% |
| 5 | Financials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
426
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $555K | ﹤0.01% |
+25,000
| New | +$555K |
|
427
Cytek Biosciences
CTKB
$522M
| $552K | ﹤0.01% |
100,000
| – | – |
|
428
MaxCyte
MXCT
$150M
| $520K | ﹤0.01% |
166,630
| – | – |
|
429
Curis
CRIS
$21.4M
| $515K | ﹤0.01% |
+78,135
| New | +$515K |
|
430
Lyra Therapeutics
LYRA
$10.9M
| $512K | ﹤0.01% |
2,617
-7,012
| -73% | -$1.37M |
|
|
SLRN
431
DELISTED
ACELYRIN
SLRN
| $509K | ﹤0.01% |
50,070
| – | – |
|
432
Cogent Biosciences
COGT
$1.77B
| $488K | ﹤0.01% |
50,000
| – | – |
|
433
Synlogic
SYBX
$17.2M
| $472K | ﹤0.01% |
168,034
| – | – |
|
|
VBIV
434
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $464K | ﹤0.01% |
+696,736
| New | +$464K |
|
435
SES AI
SES
$428M
| $454K | ﹤0.01% |
200,000
| – | – |
|
436
Advanced Micro Devices
AMD
$246B
| $411K | ﹤0.01% |
+4,000
| New | +$411K |
|
437
NewAmsterdam Pharma
NAMS
$2.83B
| $411K | ﹤0.01% |
44,432
-85,115
| -66% | -$787K |
|
|
BHIL
438
DELISTED
Benson Hill, Inc.
BHIL
| $381K | ﹤0.01% |
32,857
| – | – |
|
439
GeneDx Holdings
WGS
$3.72B
| $359K | ﹤0.01% |
98,553
| – | – |
|
440
Mineralys Therapeutics
MLYS
$2.79B
| $357K | ﹤0.01% |
37,500
| – | – |
|
441
Sweetgreen
SG
$971M
| $326K | ﹤0.01% |
27,772
-72,228
| -72% | -$849K |
|
442
Hydrofarm Holdings
HYFM
$15.2M
| $217K | ﹤0.01% |
+17,775
| New | +$217K |
|
443
Warner Bros
WBD
$30.6B
| $213K | ﹤0.01% |
19,600
-1,380,400
| -99% | -$15M |
|
|
AFMD
444
DELISTED
Affimed
AFMD
| $167K | ﹤0.01% |
35,000
| – | – |
|
445
Surrozen
SRZN
$97.4M
| $150K | ﹤0.01% |
+20,377
| New | +$150K |
|
|
AKLI
446
DELISTED
Akili, Inc. Common Stock
AKLI
| $150K | ﹤0.01% |
272,390
-400,110
| -59% | -$220K |
|
|
BIOC
447
DELISTED
Biocept, Inc.
BIOC
| $147K | ﹤0.01% |
+117,647
| New | +$147K |
|
|
WINT
448
DELISTED
Windtree Therapeutics
WINT
| $130K | ﹤0.01% |
+152
| New | +$130K |
|
|
GETR
449
DELISTED
Getaround, Inc.
GETR
| $113K | ﹤0.01% |
+325,000
| New | +$113K |
|
|
UBX
450
DELISTED
Unity Biotechnology
UBX
| $92.9K | ﹤0.01% |
+38,695
| New | +$92.9K |
|